trial · primary record
avutometinib
Low Grade Serous Ovarian Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 270 |
| Primary completion | 2031-02-09 |
| Primary endpoint | Progression Free Survival (PFS) per blinded independent central review (BICR) |
| Registry ID | NCT06072781 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:23.620Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06072781
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.